The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
ChartZero
Thursday 3/30 Insider Buying Report: MXCT, SCHW
The Online Investor - 4 hours, 51 minutes ago

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys.

On Wednesday, MaxCyte's Director, Richard Douglas, made a $345,480 purchase of MXCT, buying 80,000 shares at a cost of $4.32 a piece. Douglas was up about 8.6% on the purchase at the high point of today's trading session, with MXCT trading as high as $4.69 at last check today. MaxCyte is trading up about 5.4% on the day Thursday. This purchase marks the first one filed by Douglas in the past year.

And on Tuesday, Director Marianne Catherine Brown bought $267,340 worth of Charles Schwab, buying 5,000 shares at a cost of $53.47 a piece. This buy marks the first one filed by Brown in the past twelve months. Charles Schwab is trading off about 5.2% on the day Thursday.

3/30/2023 United States Basketball League > Shorepower Technologies
3/30/2023 Vista Equity Partners > Duck Creek Technologies
3/30/2023 Baijiayun Group Ltd > Beijing Hydrogen
More mergers & acquisitions »
3/29/2023 Avadel Pharmaceuticals plc AVDL details »
3/29/2023 Avadel Pharmaceuticals plc AVDL details »
3/29/2023 Viking Therapeutics, Inc. VKTX details »
More secondary stock offerings »
Decades of Increasing Payments: 25 S.A.F.E. Dividend Stocks
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
ETFs With Stocks The Insiders Are Buying
The Top 20 Largest U.S. Stocks By Market Cap
Top Analyst Picks of the Dow
The DividendRank Top 25
10 Stocks Where Yields Got More Juicy
Feel-Good Income: 25 Socially Responsible Dividend Stocks
10 Oversold Dividend Stocks
Top Ranked Dividend Stocks With Insider Buying
Top 25 Analyst Picks With Strong Stock Repurchase Activity
The 20 Largest ETFs
The Top 25 Lowest PE Ratios of the S&P 500
10 Stocks Going Ex-Dividend
The Top 10 DividendRank'ed DJIA Components
Current Top Analyst Picks of the S&P 500
The Top 10 DividendRank'ed Nasdaq 100 Components
The Best Performing ETFs (TTM)
The Worst Performing ETFs (TTM)
The Best Performing ETFs (Last 3 Months)
The Worst Performing ETFs (Last 3 Months)
Notable ETF Inflows
Notable ETF Outflows
25 Dividend Giants Widely Held By ETFs
10 Must-Know High-Yield REITs
10 Top DividendRank'ed Financials
10 Top DividendRank'ed Metals Stocks
10 Top DividendRank'ed Energy Stocks
10 Top DividendRank'ed Utility Stocks
Forgotten Giants of the S&P 500 — Current Least Favorites
Stock market game
March 30, 2023    7:47 PM Eastern


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Allarity Therapeutics, Inc. (ALLR)
BK Technologies Corporation (BKTI)
Cuentas, Inc. (CUEN)
More stock splits »
Hongli Group Inc.
Trailblazer Merger Corporation I
Jin Medical International Ltd.
More IPOs »
Semantix, Inc.
Minco Capital Corp.
Palisades Goldcorp Ltd.
More stock buybacks »

The Online Investor | www.TheOnlineInvestor.com | Copyright © 1998 - 2023, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.